In Vitro Antibodies – Next-Gen Science Delivers Optimized Candidates
Sponsored by: Specifica, a Q2 Solutions company
Diverse, high-affinity, developable antibodies can be generated using advanced in vitro platforms, rather than standard immunization approaches. Learn how Specifica’s platform delivers high-performing therapeutic antibodies that don’t need downstream engineering or optimization.